Viewing Study NCT02752204


Ignite Creation Date: 2025-12-24 @ 7:50 PM
Ignite Modification Date: 2026-02-23 @ 4:55 AM
Study NCT ID: NCT02752204
Status: COMPLETED
Last Update Posted: 2020-11-05
First Post: 2016-04-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Evaluation AZD2014 Alone and in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma
Sponsor: University of Birmingham
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Large B-Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed View
None Refractory View
None Lymphoma View